Home LiteratureArticle Details
PMID: 8450047 Published · ppublish English Case Reports Journal Article Research Support, Non-U.S. Gov't

Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.

The Journal of clinical investigation ·Vol. 91 ·No. 3 ·1993-03-00 ·Pages 1183-90

Ferradini L, Mackensen A, Genevée C, Bosq J, Duvillard P, Avril MF, Hercend T

Abstract

Malignant melanomas are often infiltrated by T lymphocytes. It is postulated that the presence of tumor-infiltrating lymphocytes (TIL) reflects ongoing immune responses against transformed cells. Such "responses" appear generally inefficient with the potential exception of infrequent clinical situations characterized by spontaneous tumor regression. We have characterized here the molecular structure of the T cell receptor beta chain expressed by TILs in a case of regressive melanoma. Advantage was taken of the PCR technology to study T lymphocytes directly without cell culture. Experimentally validated V beta subfamily specific primers were used to evaluate the V beta usage in TILs and control samples. Our results reveal that clonal T cell populations, precisely defined by their V-D-J junctional sequences, are amplified at the tumor site. The existence of such local antigen-driven selections support the hypothesis that antitumor responses may indeed take place in regressive melanoma.

MeSH Terms
Aged Amino Acid Sequence Antibodies, Monoclonal Base Sequence Cloning, Molecular DNA, Neoplasm/genetics,isolation & purification Female Genetic Variation Humans Immunohistochemistry Lymphocytes, Tumor-Infiltrating/immunology,pathology Melanoma/immunology,pathology Molecular Sequence Data Oligodeoxyribonucleotides Polymerase Chain Reaction/methods RNA, Neoplasm/genetics,isolation & purification Receptors, Antigen, T-Cell/genetics Receptors, Antigen, T-Cell, alpha-beta/genetics Skin Neoplasms/immunology,pathology T-Lymphocytes/immunology,pathology
Chemicals
Antibodies, Monoclonal DNA, Neoplasm Oligodeoxyribonucleotides RNA, Neoplasm Receptors, Antigen, T-Cell Receptors, Antigen, T-Cell, alpha-beta
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Ferradini L
Laboratoire d'Hémato-Immunologie, Institut National de la Santé et de la Recherche Médicale U333, Villejuif, France.
Mackensen A
Genevée C
Bosq J
Duvillard P
Avril M F
Hercend T
References (41)
41 references, click to expand
  1. Production of stable cytolytic T-cell clones directed against autologous human melanoma.
    Int J Cancer. 1987 Mar 15;39(3):390-6 PMID: 3493226
  2. Spontaneous regression of melanoma.
    Pathology. 1975 Apr;7(2):91-9 PMID: 1153228
  3. Thin malignant melanomas with regression and metastases.
    Arch Dermatol. 1987 Oct;123(10):1326-30 PMID: 3662564
  4. Immunochemical proof that a novel rearranging gene encodes the T cell receptor delta subunit.
    Science. 1987 Oct 30;238(4827):682-4 PMID: 3672118
  5. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.
    Science. 1988 Jan 29;239(4839):487-91 PMID: 2448875
  6. In transgenic mice the introduced functional T cell receptor beta gene prevents expression of endogenous beta genes.
    Cell. 1988 Mar 25;52(6):831-41 PMID: 3258191
  7. Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study.
    J Clin Oncol. 1988 May;6(5):839-53 PMID: 3259261
  8. T-cell-specific deletion of T-cell receptor transgenes allows functional rearrangement of endogenous alpha- and beta-genes.
    Nature. 1988 Jul 14;334(6178):156-9 PMID: 3260351
  9. T-cell antigen receptor genes and T-cell recognition.
    Nature. 1988 Aug 4;334(6181):395-402 PMID: 3043226
  10. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
    J Exp Med. 1988 Oct 1;168(4):1419-41 PMID: 3262710
  11. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.
    N Engl J Med. 1988 Dec 22;319(25):1676-80 PMID: 3264384
  12. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.
    Proc Natl Acad Sci U S A. 1989 Apr;86(8):2804-8 PMID: 2784858
  13. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.
    J Immunol. 1989 May 1;142(9):3329-35 PMID: 2785141
  14. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas.
    J Immunol. 1989 May 15;142(10):3714-25 PMID: 2785562
  15. Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy.
    J Immunol. 1989 Jun 15;142(12):4520-6 PMID: 2723437
  16. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
    J Exp Med. 1989 Jun 1;169(6):1961-76 PMID: 2471770
  17. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.
    J Exp Med. 1989 Sep 1;170(3):797-810 PMID: 2788708
  18. Depletion of T-cells with the CD4+CD45R+ phenotype in lymphocytes that infiltrate subcutaneous metastases of human melanoma.
    Cancer Res. 1989 Dec 1;49(23):6562-5 PMID: 2479465
  19. Quantitation of mRNA by the polymerase chain reaction.
    Proc Natl Acad Sci U S A. 1989 Dec;86(24):9717-21 PMID: 2481313
  20. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
    Eur J Immunol. 1990 Apr;20(4):825-31 PMID: 1971794
  21. Predominant expression of T cell receptor V alpha 7 in tumor-infiltrating lymphocytes of uveal melanoma.
    Science. 1990 Aug 10;249(4969):672-4 PMID: 2382141
  22. Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic response.
    J Immunol. 1990 Oct 1;145(7):2359-64 PMID: 1975829
  23. Post-transcriptional allelic exclusion of two functionally rearranged T cell receptor alpha genes.
    Int Immunol. 1989;1(3):281-8 PMID: 2562159
  24. Oligoclonal T lymphocytes infiltrating human lung cancer tissues.
    Int J Cancer. 1991 Mar 12;47(5):654-8 PMID: 1848534
  25. Each of the two productive T cell receptor alpha-gene rearrangements found in both the A10 and BM 3.3 T cell clones give rise to an alpha chain which can contribute to the constitution of a surface-expressed alpha beta dimer.
    Int Immunol. 1991 Jul;3(7):719-29 PMID: 1655004
  26. Oligoclonal expansion of V beta 8+ cells in interleukin-2-activated T cells residing in subcutaneous metastatic melanoma.
    Clin Exp Metastasis. 1992 Jan;10(1):69-76 PMID: 1531124
  27. An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction.
    Eur J Immunol. 1992 May;22(5):1261-9 PMID: 1533591
  28. Spontaneous regression of malignant melanoma: a review of the literature on incidence, clinical features, and possible mechanisms.
    Natl Cancer Inst Monogr. 1976 Nov;44:67-76 PMID: 799762
  29. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
    Biochemistry. 1979 Nov 27;18(24):5294-9 PMID: 518835
  30. Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells.
    J Natl Cancer Inst. 1981 Sep;67(3):591-601 PMID: 6944531
  31. Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex.
    J Exp Med. 1983 Feb 1;157(2):705-19 PMID: 6185617
  32. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
    Clin Exp Immunol. 1983 Jan;51(1):77-82 PMID: 6219841
  33. Prognosis in patients with thin malignant melanoma: influence of regression.
    Histopathology. 1983 Sep;7(5):673-80 PMID: 6629343
  34. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).
    J Histochem Cytochem. 1984 Feb;32(2):219-29 PMID: 6198355
  35. Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma.
    Int J Cancer. 1985 May 15;35(5):683-9 PMID: 3158614
  36. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes.
    Science. 1986 Sep 19;233(4770):1318-21 PMID: 3489291
  37. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.
    J Immunol. 1987 Feb 1;138(3):989-95 PMID: 3100623
  38. Analysis of T-cell receptor alpha/beta variability in lymphocytes infiltrating a melanoma metastasis.
    Cancer Res. 1992 Sep 1;52(17):4649-54 PMID: 1324789
  39. Spontaneous regression of primary malignant melanomas with regional metastases.
    Cancer. 1965 Nov;18(11):1399-415 PMID: 5844157
  40. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.
    Ann Surg. 1970 Nov;172(5):902-8 PMID: 5477666
  41. Multiple epitope recognition: an approach to improved radioimmunodetection of tumor-associated antigens.
    Int J Cancer. 1987 Jun 15;39(6):729-36 PMID: 2438235
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1993-03-00
Pages
1183-90
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC288075
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com